Featured on The Wall Street Journal: Biotech Company Uses Machine Learning to Find Coronavirus Therapies

“AbCellera Biologics Inc., a Canadian biotechnology startup that uses machine learning to develop antibody therapies, finds itself on the front lines of the Covidcampaign-pages/bispecifics/-19 global pandemic.”

Read full coverage on The Wall Street Journal.


Together we can make game-changing discoveries.